William Morrison provides economic analysis and expert support in antitrust and competition matters. In these contexts, Dr. Morrison has expertise in addressing claims of price fixing, tying, steering, and monopolistic pricing. He consulted on Amgen Inc.’s acquisition of Horizon Therapeutics plc, supporting expert analysis of price competition and the nature of bundled rebates in the pharmaceutical industry.
Dr. Morrison has also evaluated claims related to consumer fraud and product liability allegations, including improper disclosure claims.
Selected industry experience
- Entertainment, pharmaceuticals, and technology.
Academic research and publications
- “When do ‘Nudges’ Increase Welfare?” with Hunt Allcott, Daniel Cohen, and Dmitry Taubinsky, American Economic Review, 111:5 (2025).
- “Measuring the Welfare Effects of Shame and Pride,” with Luigi Butera, Robert Metcalfe, and Dmitry Taubinsky, American Economic Review, 112:1 (2022).
- “Rules of Thumb and Attention Elasticities: Evidence from Under- and Overreaction to Taxes,” with Dmitry Taubinsky, Review of Economics and Statistics, 85:5 (2023).